Immunoglobulin heavy chain/light chain pair measurement is associated with survival in diffuse large B-cell lymphoma

Extended Use of Serum Free Light Chain as a Biomarker in Lymphoproliferative Disorders

(2012) Khalil M. Charafeddine et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma

(2012) W. Klapper et al.   BLOOD

Abnormal serum free light chain ratio predicts poor overall survival in mantle cell lymphoma

(2012) Michelle Furtado et al.   BRITISH JOURNAL OF HAEMATOLOGY

Addition of rituximab to reduced-dose CHOP chemotherapy is feasible for elderly patients with diffuse large B-cell lymphoma

(2012) Ho-Jin Shin et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Novel M-Component Based Biomarkers in Waldenström's Macroglobulinemia

(2012) Xavier Leleu et al.   Clinical Lymphoma Myeloma & Leukemia

Plasmablastic Posttransplant Lymphoma

(2012) Heiner Zimmermann et al.   TRANSPLANTATION

Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma

(2011) Carrie A. Thompson et al.   AMERICAN JOURNAL OF HEMATOLOGY

Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia

(2011) M. J. Maurer et al.   BLOOD

Serum interleukin-18 level is associated with the outcome of patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP regimens

(2011) Naoe Goto et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA

(2011) O. Fitoussi et al.   HAEMATOLOGICA

The proportion of activated B-cell like subtype among de novo diffuse large B-cell lymphoma increases with age

(2011) S. Mareschal et al.   HAEMATOLOGICA

Elevated Serum Free Light Chains Are Associated With Event-Free and Overall Survival in Two Independent Cohorts of Patients With Diffuse Large B-Cell Lymphoma

(2011) Matthew J. Maurer et al.   JOURNAL OF CLINICAL ONCOLOGY

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial

(2011) Christian Récher et al.   LANCET

Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial

(2011) Frédéric Peyrade et al.   LANCET ONCOLOGY

The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma

(2011) P Ruminy et al.   LEUKEMIA

Interleukin-6 plasma levels are modulated by a polymorphism in theNF-κB1gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma

(2011) Manuela Giachelia et al.   LEUKEMIA & LYMPHOMA

Serum neuron-specific enolase is correlated with clinical outcome of patients with non-germinal center B cell-like subtype of diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy

(2011) Liang Wang et al.   MEDICAL ONCOLOGY

Hyperglycemia During Chemotherapy for Hematologic and Solid Tumors Is Correlated With Increased Toxicity

(2010) Antonella Brunello et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Detection of free immunoglobulin light chains in cerebrospinal fluids of patients with central nervous system lymphomas

(2010) Roland Schroers et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Vitamin D Insufficiency and Prognosis in Non-Hodgkin's Lymphoma

(2010) Matthew T. Drake et al.   JOURNAL OF CLINICAL ONCOLOGY

Assessment of Monoclonal Gammopathies by Nephelometric Measurement of Individual Immunoglobulin  /  Ratios

(2009) A. R. Bradwell et al.   CLINICAL CHEMISTRY

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

(2008) Charles H. Lawrie et al.   BRITISH JOURNAL OF HAEMATOLOGY

Quantitative assessment of serum and urinary polyclonal free light chains in patients with type II diabetes: an early marker of diabetic kidney disease?

(2008) Colin A Hutchison et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab

(2008) J-P Jais et al.   LEUKEMIA